Anti-ageing treatment
Credit: cottonbro studio, Pexels
An experimental drug successfully extended the lifespans of middle-aged mice by 25 per cent; experts find it has great potential for humans.
The researchers from the Medical Research Council Laboratory of Medical Science, Imperial College in London and Duke-NUS Medical School in Singapore, injected mice with a newly developed antibody when they were 75 weeks old; the equivalent to a human age of 55. The results were impressive.
The results
The treated mice had fewer cancers, and were free from the usual signs of ageing and frailty. We also saw reduced muscle wasting and improvement in muscle strength, revealed Professor Stuart Cook, a senior scientist in the study.
The results of the study were released on July 17 in the Nature journal, showing that the mice injected lived to an average of 155 weeks; 35 weeks longer than those untreated.
The scientists explained that by injecting the mice with the anti-IL-11 antibody, they were able to lower the incidence of diseases caused by fibrosis, chronic inflammation and poor metabolism; the hallmarks of ageing.
In the released videos, the researchers showcased the difference between the treated and untreated mice. Those untreated had greying patches, hair loss and weight gain, while the mice injected appeared in glossy coats, looking perfectly healthy.
Human potential
These findings are very exciting, said Professor Cook, emphasising; While these findings are only in mice, it raises the tantalising possibility that the drugs could have a similar effect in elderly humans.
The scientists explained that since the antibody works by blocking the action of the IL-11 protein, which affects the ageing of cells and body tissues, it could potentially work on humans, who go through the same process of ageing.
There´s a real opportunity here to translate this into clinical therapies, said Cathy Slack, a student of the biology of ageing at the University of Warwick, UK. Today, there are already drug candidates that block IL-11 in human trials to treat cancer and fibrosis.
Opposing views
Anti-ageing drugs have always been a matter of discussion, especially during tests conducted on animals. Ilaria Bellantuono, professor of musculoskeletal ageing at the University of Sheffield said; The problem with all these interventions is that we do not have evidence in patients. It is unthinkable to treat every 50-year-old for the rest of their life. Every drug has side effects and there is a cost associated with it.
Side effects?
Yet, the researchers noted that, unlike previous experiments, this antibody showed no side effects; Previously proposed life-extending drugs and treatments have either had poor side-effect profiles, or don´t work in both sexes, or could extend life, but not healthy life however this does not appear to be the case for IL-11, said Professor Cook.
A 2021 study by Statista showed that the global anti-ageing market was estimated to be worth more than €56 billion and is only expected to rise, showing that today, a large majority of people are willing to pay the price to avoid ageing.
Sign up for personalised news
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our
Privacy Policy for more information about our privacy practices.
Originally from Moscow, with Russian and Armenian origins, Anna has lived in Costa Blanca for over ten years. She is passionate about singing, acting and traveling.
Leave a comment Cancel reply
Your email address will not be published. Required fields are marked *
Website
Comment for robots
Known as the PEOPLE’S PAPER, Euro Weekly News is the leading English language newspaper in Spain. And it’s FREE!
Covering the Costa del Sol, Costa Blanca, Almeria, Axarquia, Mallorca and beyond, EWN supports and inspires the individuals, neighbourhoods, and communities we serve, by delivering news with a social conscience. Whether it’s local news in Spain, UK news or international stories, we are proud to be the voice for the expat communities who now call Spain home.
With around half a million print readers a week and over 1.5 million web views per month, EWN has the biggest readership of any English language newspaper in Spain. The paper prints over 150 news stories a week with many hundreds more on the web – no one else even comes close.
Our publication has won numerous awards over the last 25 years including Best Free Newspaper of the Year (Premios AEEPP), Company of the Year (Costa del Sol Business Awards) and Collaboration with Foreigners honours (Mijas Town Hall). All of this comes at ZERO cost to our readers. All our print and online content always has been and always will be FREE OF CHARGE.
Sign up for personalised news
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Close
